BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 1219453)

  • 21. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A; Giorgi-Rossi P; Sangalli M; Spadea T; Perucci CA
    Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract]   [Full Text] [Related]  

  • 22. [Issues related to rubella, measles and epidemic parotiditis in the Russian Federation].
    Zverev VV; Iuminova NV
    Vopr Virusol; 2004; 49(3):8-11. PubMed ID: 15188648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
    Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid effect on endemic measles, mumps, and rubella of nationwide vaccination programme in Finland.
    Peltola H; Karanko V; Kurki T; Hukkanen V; Virtanen M; Penttinen K; Nissinen M; Heinonen OP
    Lancet; 1986 Jan; 1(8473):137-9. PubMed ID: 2867355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with a combined vaccine against measles, mumps and rubella aiming at elimination of the three diseases.
    Böttiger M; Christenson B; Strandell A; Romanus V
    Dev Biol Stand; 1986; 65():37-43. PubMed ID: 3556776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles/mumps/rubella vaccine.
    Lancet; 1988 Oct; 2(8615):860. PubMed ID: 2902310
    [No Abstract]   [Full Text] [Related]  

  • 28. [Elimination of measles, mumps and rubella in Switzerland].
    Herzog C
    Soz Praventivmed; 1986; 31(6):326-9. PubMed ID: 3811611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mumps and rubella consensus conference.
    Can Commun Dis Rep; 1994 Oct; 20(19):165-76. PubMed ID: 7804152
    [No Abstract]   [Full Text] [Related]  

  • 30. [Rubella, measles, mumps--epidemiologic, occupational medicine significance and efficacy of adult vaccination].
    Hofmann F; Sydow B
    Offentl Gesundheitswes; 1989 Jun; 51(6):299-302. PubMed ID: 2526940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MMR vaccine--one year on.
    Walker D
    Practitioner; 1990 May; 234(1489):550-2. PubMed ID: 2392406
    [No Abstract]   [Full Text] [Related]  

  • 32. [Measles, mumps and rubella vaccination status of school beginners in Munich].
    Markuzzi A; Schlipköter U; Weitkunat R; Meyer G
    Soz Praventivmed; 1997; 42(3):133-43. PubMed ID: 9334085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of a trivalent combined vaccine against measles, parotiditis and rubella].
    Randall AG; Leonard JM
    Salud Publica Mex; 1971; 13(3):313-7. PubMed ID: 5164661
    [No Abstract]   [Full Text] [Related]  

  • 34. A second dose of MMR vaccine for children in the United Kingdom.
    Commun Dis Rep CDR Wkly; 1996 Jul; 6(30):259. PubMed ID: 8755703
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of live trivalent vaccine of measles AIK-C strain, mumps Hoshino strain and rubella Takahashi strain, by virus-specific interferon-gamma production and antibody response.
    Nakayama T; Urano T; Osano M; Nakagawa M; Maehara N; Sasaki K; Yamamura AM; Makino S
    Microbiol Immunol; 1990; 34(6):497-508. PubMed ID: 2120551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two doses of MMR vaccine--sufficient to eradicate measles, mumps and rubella?
    Fahlgren K
    Scand J Soc Med; 1988; 16(3):129-35. PubMed ID: 3057621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.
    Böttiger M; Christenson B; Romanus V; Taranger J; Strandell A
    Br Med J (Clin Res Ed); 1987 Nov; 295(6608):1264-7. PubMed ID: 3120971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.
    Heath TC; Burgess MA; Forrest JM
    Commun Dis Intell; 1998 Aug; 22(8):157-8. PubMed ID: 9735550
    [No Abstract]   [Full Text] [Related]  

  • 39. Serological evaluation of 52 children immunized with the combined measles, mumps and rubella vaccine.
    Topal B; Kanra G; Ceyhan M
    Turk J Pediatr; 1991; 33(1):13-8. PubMed ID: 1844171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.
    Bart KJ; Orenstein WA; Hinman AR
    Dev Biol Stand; 1986; 65():45-52. PubMed ID: 3104117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.